Product Pathways
BCP0005 Gemcitabine Hydrochloride
A new pyrimidine antimetabolite which has shown good clinical activ.A nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer.
BCP0007 GSK461364
GSK461364 is an ATP-competitive inhibitor of Plk1 and forms a rapidly reversible complex with Plk1.
BCP0028 BI2536
Potent and selective polo-like kinase (PLK) 1 inhibitor.
BCP0109 Roscovitine
Roscovitine is a potent and selective inhibitor of cyclin-dependent kinases (CDK).
BCP0039 Capecitabine(Xeloda)
Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
BCP0050 Docetaxel(Taxotere)
Docetaxel (Taxotere) is an microtubule disassembly inhibitor with IC50 of a range of 0.31-100 ηM.
BCP0231 JNJ7706621
JNJ-7706621 is a novel cell cycle inhibitor that showed potentv inhibition of several cyclin-dependent kinases (CDK) and Aurora kinases.
BCP0088 Paclitaxel (Taxol)
Paclitaxel (Taxol, Onxol, Nov-Onxol) is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.
BCP0092 PD0332991
PD-0332991 is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity.
BCP0094 Pemetrexed disodium
Pemetrexed disodium (Alimta) is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively.
第一页 1 2 3 4 5 6 7 8 9 10 下10页 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.